Web Analytics

3 Latest Announced Rounds

  • $80,000,000
    Series C

    2 Investors

    IT Services and IT Consulting
    Sep 27th, 2024
  • $2,143,528
    Seed

    1 Investors

    Computer & Network Security
    Sep 27th, 2024
  • $12,000,000
    Pre-Seed

    2 Investors

    Research Services
    Sep 27th, 2024
$1,390.46M Raised in 84 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Advanced NanoTherapies, Inc

start up
United States - Los Gatos, California
  • 23/08/2023
  • Unknown
  • $4,000,000

AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention.

We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).


Related People

Marwan Berrada-SounniCo Founder

Marwan Berrada-Sounni United States - Los Gatos, California

With over 20 years of experience in medical device product development, commercialization, and entrepreneurship, I am the CEO and co-founder of Advanced NanoTherapies Inc. This company is revolutionizing the treatment of peripheral arterial disease with biodegradable nanoparticle technology. Our innovative Dual-API-based Drug Coated Balloons (DCB) deliver higher cellular uptake and retention, improving patient outcomes and reducing complications.

As a biomedical engineer and a business development professional, I have a proven track record of launching and leading successful medical device ventures, from seed funding to first-in-man and early sales. I have extensive clinical and device expertise in percutaneous therapies such as electrophysiology, structural heart, cardiovascular, and endovascular devices. I have also obtained patents, FDA approvals, and 510(k) clearances for novel devices and technologies. I am passionate about creating value for patients, physicians, and investors by developing and delivering cutting-edge solutions for unmet medical needs.